APO M10 (Montelukast sodium 10 mg (base))

Pill imprint APO M10 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of bronchospasm prophylaxis; asthma, maintenance; hay fever; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for APO M10

Montelukast sodium 10 mg (base) APO M10
Montelukast sodium
Imprint:
APO
M10
Strength:
10 mg (base)
Color:
Beige
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-3562
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
silicon dioxide
magnesium stearate
hypromellose 2910 (5 mPa.s)
hydroxypropyl cellulose
titanium dioxide
ferric oxide red
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)